Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke

Yajing Chen, Fanxia Shen, Jianrong Liu, Guo-Yuan Yang, Yajing Chen, Fanxia Shen, Jianrong Liu, Guo-Yuan Yang

Abstract

Stroke is the second leading cause of mortality and morbidity worldwide. Early intervention is of great importance in reducing disease burden. Since the conventional risk factors cannot fully account for the pathogenesis of stroke, it is extremely important to detect useful biomarkers of the vascular disorder for appropriate intervention. Arterial stiffness, a newly recognised reliable feature of arterial structure and function, is demonstrated to be associated with stroke onset and serve as an independent predictor of stroke incidence and poststroke functional outcomes. In this review article, different measurements of arterial stiffness, especially pressure wave velocity, were discussed. We explained the association between arterial stiffness and stroke occurrence by discussing the secondary haemodynamic changes. We reviewed clinical data that support the prediction role of arterial stiffness on stroke. Despite the lack of long-term randomised double-blind controlled therapeutic trials, it is high potential to reduce stroke prevalence through a significant reduction of arterial stiffness (which is called de-stiffening therapy). Pharmacological interventions or lifestyle modification that can influence blood pressure, arterial function or structure in either the short or long term are promising de-stiffening therapies. Here, we summarised different de-stiffening strategies including antihypertension drugs, antihyperlipidaemic agents, chemicals that target arterial remodelling and exercise training. Large and well-designed clinical trials on de-stiffening strategy are needed to testify the prevention effect for stroke. Novel techniques such as modern microscopic imaging and reliable animal models would facilitate the mechanistic analyses in pathophysiology, pharmacology and therapeutics.

Keywords: Arterial Stiffness; Blood Pressure; De-stiffening; Pulse Wave Velocity; Stroke.

Conflict of interest statement

Competing interests: None declared.

References

    1. Lozano R, Naghavi M, Foreman K, et al. . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095–128.
    1. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. . Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 2014;383:245–54.
    1. Shirwany NA, Zou MH. Arterial stiffness: a brief review. Acta Pharmacol Sin 2010;31:1267–76.
    1. Urbina EM, Williams RV, Alpert BS, et al. . Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 2009;54:919–50.
    1. McEniery CM, Wallace S, Mackenzie IS, et al. . Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 2006;48:602–8.
    1. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. . Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006;113:657–63.
    1. Gasecki D, Rojek A, Kwarciany M, et al. . Aortic stiffness predicts functional outcome in patients after ischemic stroke. Stroke 2012;43:543–4.
    1. Tuttolomondo A, Di Sciacca R, Di Raimondo D, et al. . Arterial stiffness indexes in acute ischemic stroke: relationship with stroke subtype. Atherosclerosis 2010;211:187–94.
    1. Yoon HJ, Kim KH, Lee SH, et al. . Differences of aortic stiffness and aortic intima-media thickness according to the type of initial presentation in patients with ischemic stroke. J Cardiovasc Ultrasound 2013;21:12–7.
    1. Suzuki J, Sakakibara R, Tomaru T, et al. . Stroke and cardio-ankle vascular stiffness index. J Stroke Cerebrovasc Dis 2013;22:171–5.
    1. Ghasemzadeh N, Zafari AM. A brief journey into the history of the arterial pulse. Cardiol Res Pract 2011;2011:164832
    1. Laurent S, Cockcroft J, Van Bortel L, et al. . Abridged version of the expert consensus document on arterial stiffness. Artery Res 2007;1:2–12.
    1. Laurent S, Cockcroft J, Van Bortel L, et al. . Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588–605.
    1. Mancia G, Fagard R, Narkiewicz K, et al. . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–219.
    1. Shirai K, Hiruta N, Song M, et al. . Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 2011;18:924–38.
    1. Takata M, Shimakura A. [Cardio-ankle vascular index (CAVI) and cardiovascular disease]. Rinsho Byori 2013;61:924–33.
    1. Kubozono T, Miyata M, Ueyama K, et al. . Clinical significance and reproducibility of new arterial distensibility index. Circ J 2007;71:89–94.
    1. Yoshinaga K, Fujii S, Tomiyama Y, et al. . Anatomical and functional estimations of brachial artery diameter and elasticity using oscillometric measurements with a quantitative approach. Pulse (Basel) 2016;4:1–10.
    1. Segers P, Kips J, Trachet B, et al. . Limitations and pitfalls of non-invasive measurement of arterial pressure wave reflections and pulse wave velocity. Artery Res 2009;3:79–88.
    1. Safar ME, Blacher J, Pannier B, et al. . Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002;39:735–8.
    1. Chirinos JA. Arterial stiffness: basic concepts and measurement techniques. J Cardiovasc Transl Res 2012;5:243–55.
    1. Liao YC, Liu PY, Lin HF, et al. . Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression. J Mol Cell Cardiol 2015;79:180–6.
    1. Lacolley P, Challande P, Osborne-Pellegrin M, et al. . Genetics and pathophysiology of arterial stiffness. Cardiovasc Res 2009;81:637–48.
    1. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:932–43.
    1. Francis-Sedlak ME, Uriel S, Larson JC, et al. . Characterization of type I collagen gels modified by glycation. Biomaterials 2009;30:1851–6.
    1. Tam LS, Shang Q, Li EK, et al. . Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis—a prospective study. Semin Arthritis Rheum 2013;42:333–45.
    1. van Gorp AW, Schenau DS, Hoeks AP, et al. . In spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. Am J Physiol Heart Circ Physiol 2000;278:H1241–7.
    1. Lloyd-Jones DM, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 1996;47:365–75.
    1. Kinlay S, Creager MA, Fukumoto M, et al. . Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 2001;38:1049–53.
    1. Lacolley P, Ghodsi N, Glazer E, et al. . Influence of graded changes in vasomotor tone on the carotid arterial mechanics in live spontaneously hypertensive rats. Br J Pharmacol 1995;115:1235–44.
    1. Brillante DG, O'Sullivan AJ, Howes LG. Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptors. Vasc Health Risk Manag 2009;5:73–8.
    1. Safar ME, Blacher J, Jankowski P. Arterial stiffness, pulse pressure, and cardiovascular disease—is it possible to break the vicious circle? Atherosclerosis 2011;218:263–71.
    1. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005;46:200–4.
    1. van Sloten TT, Stehouwer CD. Carotid stiffness: a novel cerebrovascular disease risk factor. Pulse (Basel) 2016;4:24–7.
    1. Saji N, Toba K, Sakurai T. Cerebral small vessel disease and arterial stiffness: tsunami effect in the brain? Pulse (Basel) 2016;3:182–9.
    1. van Sloten TT, Protogerou AD, Henry RM, et al. . Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: a systematic review and meta-analysis. Neurosci Biobehav Rev 2015;53:121–30.
    1. Singer J, Trollor JN, Baune BT, et al. . Arterial stiffness, the brain and cognition: a systematic review. Ageing Res Rev 2014;15:16–27.
    1. Dart AM, Lacombe F, Yeoh JK, et al. . Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet 1991;338:270–3.
    1. Blacher J, Guerin AP, Pannier B, et al. . Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434–9.
    1. Sugioka K, Hozumi T, Sciacca RR, et al. . Impact of aortic stiffness on ischemic stroke in elderly patients. Stroke 2002;33:2077–81.
    1. Saeed S, Waje-Andreassen U, Fromm A, et al. . Early vascular aging in young and middle-aged ischemic stroke patients: the Norwegian Stroke in the Young Study. PLoS ONE 2014;9:e112814
    1. Tsai WC, Sun YT, Liu YW, et al. . Usefulness of vascular wall deformation for assessment of carotid arterial stiffness and association with previous stroke in elderly. Am J Hypertens 2013;26:770–7.
    1. Blacher J, Pannier B, Guerin AP, et al. . Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998;32:570–4.
    1. Meaume S, Benetos A, Henry OF, et al. . Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001;21:2046–50.
    1. Laurent S, Boutouyrie P, Asmar R, et al. . Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236–41.
    1. Laurent S, Katsahian S, Fassot C, et al. . Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003;34:1203–6.
    1. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. . Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005;111:3384–90.
    1. Ben-Shlomo Y, Spears M, Boustred C, et al. . Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014;63:636–46.
    1. van Sloten TT, Sedaghat S, Laurent S, et al. . Carotid stiffness is associated with incident stroke: a systematic review and individual participant data meta-analysis. J Am Coll Cardiol 2015;66:2116–25.
    1. Lee YB, Park JH, Kim E, et al. . Arterial stiffness and functional outcome in acute ischemic stroke. J Cerebrovasc Endovasc Neurosurg 2014;16:11–9.
    1. Wohlfahrt P, Krajcoviechova A, Jozifova M, et al. . Large artery stiffness and carotid flow pulsatility in stroke survivors. J Hypertens 2014;32:1097–103; discussion 103
    1. Kim YB, Park KY, Chung PW, et al. . Brachial-ankle pulse wave velocity is associated with both acute and chronic cerebral small vessel disease. Atherosclerosis 2016;245:54–9.
    1. Poels MM, Zaccai K, Verwoert GC, et al. . Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study. Stroke 2012;43:2637–42.
    1. Mitchell GF, van Buchem MA, Sigurdsson S, et al. . Arterial stiffness, pressure and flow pulsatility and brain structure and function: the age, gene/environment susceptibility—Reykjavik study. Brain 2011;134(Pt 11):3398–407.
    1. Masawa N, Yoshida Y, Yamada T, et al. . Morphometry of structural preservation of tunica media in aged and hypertensive human intracerebral arteries. Stroke 1994;25:122–7.
    1. Ong KT, Delerme S, Pannier B, et al. . Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens 2011;29:1034–42.
    1. Hayoz D, Zappe DH, Meyer MA, et al. . Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen. J Clin Hypertens (Greenwich) 2012;14:773–8.
    1. Bramlage P, Zemmrich C, Ketelhut R, et al. . Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice. Vasc Health Risk Manag 2013;9:475–83.
    1. Safar ME, Jankowski P. Antihypertensive therapy and de-stiffening of the arteries. Expert Opin Pharmacother 2010;11:2625–34.
    1. Cameron JD, Asmar R, Struijker-Boudier H, et al. . Current and future initiatives for vascular health management in clinical practice. Vasc Health Risk Manag 2013;9:255–64.
    1. Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens 2008;21:663–7.
    1. Janić M, Lunder M, Sabovič M. Arterial stiffness and cardiovascular therapy. Biomed Res Int 2014;2014:621437
    1. Wu CF, Liu PY, Wu TJ, et al. . Therapeutic modification of arterial stiffness: an update and comprehensive review. World J Cardiol 2015;7:742–53.
    1. Rehman A, Leibowitz A, Yamamoto N, et al. . Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2012;59:291–9.
    1. Ceconi C, Fox KM, Remme WJ, et al. . ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 2007;73:237–46.
    1. Bots ML, Remme WJ, Luscher TF, et al. . ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trial. Cardiovasc Drugs Ther 2007;21:269–79.
    1. Protogerou AD, Stergiou GS, Vlachopoulos C, et al. . The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des 2009;15:272–89.
    1. London GM. [Arterial stiffness, wave reflections and myocardial protection: the REASON project]. Drugs 2003;63:9–17.
    1. Kengne AP, Czernichow S, Huxley R, et al. . Blood pressure variables and cardiovascular risk: new findings from ADVANCE. Hypertension 2009;54:399–404.
    1. Mahmud A, Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens 2002;15:321–5.
    1. Frimodt-Moller M, Kamper AL, Strandgaard S, et al. . Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease—a randomized trial. PLoS ONE 2012;7:e41757
    1. MacMahon S, Rodgers A, Neal B, et al. . Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–41.
    1. Patel A. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829–40.
    1. Ishimitsu T, Numabe A, Masuda T, et al. . Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension. Hypertens Res 2009;32:962–8.
    1. Doi M, Miyoshi T, Hirohata S, et al. . Combination therapy of calcium channel blocker and angiotensin II receptor blocker reduces augmentation index in hypertensive patients. Am J Med Sci 2010;339:433–9.
    1. Mahmud A, Feely J. Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens 2002;15:1092–5.
    1. Ferguson JM, Minas J, Siapantas S, et al. . Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension. J Cardiovasc Pharmacol 2008;51:590–5.
    1. Manisty CH, Hughes AD. Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index. Br J Clin Pharmacol 2013;75:79–92.
    1. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005;366:1545–53.
    1. Koumaras C, Tziomalos K, Stavrinou E, et al. . Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness. J Am Soc Hypertens 2014;8:74–82.
    1. Polonia J, Barbosa L, Silva JA, et al. . Different patterns of peripheral versus central blood pressure in hypertensive patients treated with beta-blockers either with or without vasodilator properties or with angiotensin receptor blockers. Blood Press Monit 2010;15:235–9.
    1. Rizos EC, Agouridis AP, Elisaf MS. The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review. Curr Vasc Pharmacol 2010;8:638–44.
    1. Kanaki AI, Sarafidis PA, Georgianos PI, et al. . Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia. Am J Hypertens 2013;26:608–16.
    1. Hongo M, Tsutsui H, Mawatari E, et al. . Fluvastatin improves arterial stiffness in patients with coronary artery disease and hyperlipidemia: a 5-year follow-up study. Circ J 2008;72:722–8.
    1. Benjamin MM, Khalil RA. Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease. EXS 2012;103:209–79.
    1. Guimaraes DA, Rizzi E, Ceron CS, et al. . Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension. Basic Clin Pharmacol Toxicol 2011;108:318–25.
    1. Susic D, Frohlich ED. Increased collagen, per se, may not affect left ventricular function in spontaneously hypertensive rats. Ochsner J 2011;11:241–5.
    1. Shapiro BP, Owan TE, Mohammed SF, et al. . Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines. Circulation 2008;118:1002–10.
    1. Chang KC, Hsu KL, Tseng CD, et al. . Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats. Br J Pharmacol 2006;147:944–50.
    1. Zieman SJ, Melenovsky V, Clattenburg L, et al. . Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens 2007;25:577–83.
    1. Oudegeest-Sander MH, Olde Rikkert MG, Smits P, et al. . The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial. Exp Gerontol 2013;48:1509–17.
    1. Little WC, Zile MR, Kitzman DW, et al. . The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail 2005;11:191–5.
    1. Tanaka H, Dinenno FA, Monahan KD, et al. . Aging, habitual exercise, and dynamic arterial compliance. Circulation 2000;102:1270–5.
    1. Tanaka H, DeSouza CA, Seals DR. Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol 1998;18:127–32.
    1. Tanaka M, Sugawara M, Ogasawara Y, et al. . Intermittent, moderate-intensity aerobic exercise for only eight weeks reduces arterial stiffness: evaluation by measurement of stiffness parameter and pressure-strain elastic modulus by use of ultrasonic echo tracking. J Med Ultrason (2001) 2013;40:119–24.
    1. Madden KM, Lockhart C, Cuff D, et al. . Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Diabetes Care 2009;32:1531–5.
    1. Tabara Y, Yuasa T, Oshiumi A, et al. . Effect of acute and long-term aerobic exercise on arterial stiffness in the elderly. Hypertens Res 2007;30:895–902.
    1. Tang A, Eng JJ, Krassioukov AV, et al. . Exercise-induced changes in cardiovascular function after stroke: a randomized controlled trial. Int J Stroke 2014;9:883–9.
    1. Seals DR, Walker AE, Pierce GL, et al. . Habitual exercise and vascular ageing. J Physiol (Lond) 2009;587:5541–9.
    1. Zhu Z, Zhang H, Yao W, et al. . Physical activity modifies the association between CYBA gene polymorphisms and small artery elasticity in a Chinese population. Hypertens Res 2012;35:739–44.
    1. Ashor AW, Lara J, Siervo M, et al. . Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE 2014;9:e110034
    1. Madden KM, Lockhart C, Cuff D, et al. . Aerobic training-induced improvements in arterial stiffness are not sustained in older adults with multiple cardiovascular risk factors. J Hum Hypertens 2013;27:335–9.
    1. Yoon ES, Jung SJ, Cheun SK, et al. . Effects of acute resistance exercise on arterial stiffness in young men. Korean Circ J 2010;40:16–22.
    1. Miyachi M. Effects of resistance training on arterial stiffness: a meta-analysis. Br J Sports Med 2013;47:393–6.
    1. Sadekova N, Vallerand D, Guevara E, et al. . Carotid calcification in mice: a new model to study the effects of arterial stiffness on the brain. J Am Heart Assoc 2013;2:e000224
    1. Guan Y, Wang Y, Yuan F, et al. . Effect of suture properties on stability of middle cerebral artery occlusion evaluated by synchrotron radiation angiography. Stroke 2012;43:888–91.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever